ArticleInternal medicine (Tokyo, Japan)2020

Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center.

Chinatsu Takai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.